Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Demirci

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 16, 2011
Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failureN Alkis, U Demirci, M Benekli, et al.
Scientific Reports|December 8, 2022
A proof of concept for a deep learning system that can aid embryologists in predicting blastocyst survival after thawP Marsh, D Radif, P Rajpurkar, et al.
Transplantation Proceedings|August 19, 2014
Evaluation of epithelial chimerism after bone marrow mesenchymal stromal cell infusion in intestinal transplant patientsS Kilinc, U A Gurkan, S Guven, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 25, 2013
Endocrine therapy alone vs. chemotherapy plus endocrine therapies for the treatment of elderly patients with endocrine-responsive and node positive breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology)A Inal, T Akman, S Yaman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2025
Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: Results from the randomised, global phase III CAPItello-290 trialP S Schmid, H L McArthur, J Cortés, et al.
Cancer Chemotherapy and Pharmacology|November 1, 2018
Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomesEce Esin, B Oksuzoglu, A Bilici, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 16, 2011
Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failureN Alkis, U Demirci, M Benekli, et al.
Scientific Reports|December 8, 2022
A proof of concept for a deep learning system that can aid embryologists in predicting blastocyst survival after thawP Marsh, D Radif, P Rajpurkar, et al.
Transplantation Proceedings|August 19, 2014
Evaluation of epithelial chimerism after bone marrow mesenchymal stromal cell infusion in intestinal transplant patientsS Kilinc, U A Gurkan, S Guven, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 25, 2013
Endocrine therapy alone vs. chemotherapy plus endocrine therapies for the treatment of elderly patients with endocrine-responsive and node positive breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology)A Inal, T Akman, S Yaman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2025
Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: Results from the randomised, global phase III CAPItello-290 trialP S Schmid, H L McArthur, J Cortés, et al.
Cancer Chemotherapy and Pharmacology|November 1, 2018
Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomesEce Esin, B Oksuzoglu, A Bilici, et al.
Pageof 2